Free Newsletter
Pilot to streamline international inspections
The European Directorate for the Quality of Medicines has established bilateral confidentiality agreements with the U.S. FDA and the Australian Therapeutic Goods Administration to share information regarding inspections of active pharmaceutical ingredients (API) and excipients manufacturers. The three organizations are involved in a pilot project to rationalize international good manufacturing practices (GMP) inspections. Release
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
SHARE
WITH: